Pharmaceutical giant Johnson & Johnson on Friday agreed to a $26 billion settlement to thousands of claims by local and state governments of the alleged role that it and several others played in the U.S. opioid crisis.
In February 2020, the Trump administration drafted a policy document—stamped “not for public distribution or release” and indeed kept from public view for months—that would guide decision makers at every level of government and every sector of the economy in dealing with a new virus that came to be known by the scientific shorthand “Covid-19.”
$30 million grant funds pipes for smoking crack cocaine and crystal methamphetamine, while DOJ considers facilitating locations for taking illegal drugs.
On 730 Polk Street in the Tenderloin neighborhood of San Francisco sits a safe syringe access center, St. James Infirmary, where clean syringes and other drug use supplies are provided every Tuesday evening. Narcan—a lifesaving drug that reverses the effects of an overdose—is also distributed.
On the same day a jury convicted disgraced socialite Ghislaine Maxwell on five of six counts of sex trafficking related to her former lover Jeffrey Epstein, another Epstein associate received ominous legal news.
U.S. drug agents are expanding operations in China – six years after America’s largest trading partner and global rival emerged as the main source of chemicals used to make highly lethal fentanyl. It’s now claiming 65,000 American lives a year.
